Diversified Healthcare Trust (DHC) stock soared 5.10% in Wednesday's intraday trading session, following the company's fourth-quarter 2024 earnings report that showed improved performance compared to the previous year.
According to the earnings summary, DHC reported a quarterly adjusted loss of $0.36 per share for the quarter ended December 31, 2024, which was an improvement from the loss of $0.43 per share reported in the same quarter last year. While the company missed the analyst consensus estimate of a $0.29 per share loss, the narrowing loss and revenue growth of 5% to $379.62 million, beating analyst expectations of $370.97 million, seem to have contributed to the stock's gains.
Despite the positive revenue and earnings trends, analyst recommendations on DHC remain mixed, with no "strong buy" or "buy" ratings, one "hold," and one "sell" or "strong sell" rating. The average consensus recommendation for the specialized REITs peer group is "sell," indicating a cautious outlook from analysts on the company and the sector.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.